As for valuation, ZD currently trades at 7.2x forward EBITDA, about 20% lower than its 10-year average of 8.9x. I believe this 20% is warranted given the macro environment. Hence, I assumed...
The advances in cancer research on next-generation oncology devices and solutions have led to the development of various prognosis and treatment procedures for patients with a wide range of hematological and solid malignancies.
Immunotherapy...
Everyone in financial media is singing in unison, and the song they are all singing is a recessional for the recession — a hymn or musical piece sung while...
Cardano (ADA) was enjoying the uptrend last month. Following the price rally that insinuated a rise in the entire crypto market, crypto prices have nosedived again in the past week.
ADA prices reaches buy...
